Lung cancer chemoprevention

Seminars in Surgical Oncology

Volumn 18, Issue 2, 2000, Pages 100-105

  Khuri, Fadlo R ^a   Lippman, Scott M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anticarcinogenic agents; Beta carotene; Chemoprevention; Genetic markers; Incidence; Isotretinoin; Loss of heterozygosity; Lung neoplasms; Mortality; Neoplasms prevention and control; Phase III clinical trials; Randomized controlled trials; Retinoids; Second primary neoplasms; Selenium; Smoking; Tobacco use disorder; Vitamin A; Vitamin B12; Vitamin E

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; BETA CAROTENE; CYANOCOBALAMIN; FOLIC ACID; ISOTRETINOIN; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE; RETINOL PALMITATE; SELENIUM;

CANCER CONTROL; CANCER RISK; CHEMOPROPHYLAXIS; HETEROZYGOSITY LOSS; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MALE; PRECANCER; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS, PHASE III; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RETINOIDS; SELENIUM; VITAMIN E;

EID: 0033966392     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(200003)18:2<100::AID-SSU3>3.0.CO;2-9     Document Type: Review

References (46)

1. Sporn MB, Dunlop NM, Newton DL, Smith JM: Prevention of chemical carcinogenesis by vitamin A and its synthetic analogues (retinoids) [Review]. Fed Proc 1976;35:1332-1338.
2. Lippman SM, Benner SE, Hong WK: Cancer chemoprevention [Review]. J Clin Oncol 1994;12:851-873.
3. Lippman SM, Lee JJ, Sabichi AL: Cancer chemoprevention: progress and promise [Review]. J Natl Cancer Inst 1998;90:1514-1528.
4. Hong WK, Endicott J, Itri LM, et al: 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315:1501-1505.
5. Lippman SM, Batsakis JG, Toth BB, et al: Comparison of low-dose isotretinoin with β-carotene to prevent oral carcinogenesis. N Engl J Med 1993;328:15-20.
6. Hong WK, Lippman SM, Itri LM, et al: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
7. Vokes EE, Weichselbaum RR, Lippman SM, et al: Head and neck cancer [Review]. N Engl J Med 1993;328:184-194.
8. th ed. Philadelphia (PA): Lippincott-Raven; 1997. p. 585-599.
9. Hong WK, Sporn MB: Recent advances in chemoprevention of cancer [Review]. Science 1997;278(5340):1073-1077.
10. nd ed. New York: Raven Press; 1994, p. 319-349.
11. Mukherjee R, Davies PJ, Crombie DL, et al: Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 1997;386(6623):407-410.
12. Sun SY, Li W, Yue P, et al: Mediation of N-(4-hydroxyphenyl)-retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res 1999;59:2493-2498.
13. nd ed. New York: Raven Press; 1994, p. 573-596.
14. Lippman SM, Lee JS, Lotan R, et al: Biomarkers as intermediate end points in chemoprevention trials [Review]. J Natl Cancer Inst 1990;82:555-560.
15. Hong WK, Lippman SM, Hittelman WN, Lotan R: Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic [Review]. Clin Cancer Res 1995;1:677-686.
16. Mao L, Lee JS, Kurie JM, et al: Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997; 89:857-862.
17. Arnold AM, Browman GP, Levine MN, et al: The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomized trial. Br J Cancer 1992;65:737-743.
18. Lee JS, Lippman SM, Benner SE, et al: A randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 1994;12:937-945.
19. Kurie JM, Lee JS, Khuri FR, et al: 4-Hydroxyphenylretinamide (4-HPR) in the reversal of bronchial metaplasia and dysplasia in smokers [Abstract]. Proc Am Soc Clin Oncol 1999;18:473a.
20. Heimburger DC, Alexander B, Birch R, et al: Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B 12. Report of a preliminary randomized, double-blind intervention trial [published erratum appears in JAMA 1988;259: 3410]. JAMA 1988;259:1525-1530.
21. McLarty JW, Holiday DB, Girard WM, et al: β-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr 1995;62(6 Suppl):1431S-1438S.
22. Kurie JM, Lee JS, Morice RC, et al: Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst 1998;90:991-995.
23. Mao L, Lee JS, Fan YH, et al: Frequent microsatellite alterations at chromosome 9p21 and 3p14 in oral premalignant lesions and its value in cancer risk assessment. Nat Med 1996;2:682-685.
24. Lotan R, Xu XC, Lippman SM, et al: Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995;332:1405-1410.
25. Xu XC, Lee JS, Lee JJ, et al: Nuclear retinoid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J Natl Cancer Inst 1999;91:1317-1321.
26. Ayoub J, Jean-Francois R, Cormier Y, et al: Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acid receptor-beta expression in a population at high risk: implications for chemoprevention of lung cancer. J Clin Oncol 1999;17:3546-3552.
27. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-1035.
28. Omenn GS, Goodman GE, Thornquist MD, et al: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-1155.
29. Hennekens CH, Buring JE, Manson JE, et al: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-1149.
30. Wang XD, Liu C, Bronson RT, et al: Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999;91:60-66.
31. Salgo MG, Cueto R, Winston GW, Pryor WA: Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic Biol Med 1999; 26:162-173.
32. Paolini M, Cantelli-Forti G, Peroccot P, et al: Co-carcinogenic effect of β-carotene [letter]. Nature 1999;398(6730):760-761.
33. Pastorino U, Infante M, Maioli M, et al: Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-1222.
34. Van Zandwijk N, Pastorino U, De Vries N, et al: Randomized trial of chemoprevention with vitamin A and N-acetylcysteine in patients with cancer of the upper and lower airways: the Euroscan study [Abstract]. Proc Am Soc Clin Oncol 1999;18:464a.
35. Lippman SM, Lee JJ, Karp DD, et al: Phase III Intergroup trial of 13-cis-retinoic acid to prevent second primary tumors in stage I non-small cell lung cancer (NSCLC): Interim Report of NCI #119-0001 [Abstract]. Proc Amer Soc Clin Oncol 1998;17:456a.
36. Woodson K, Tangrea JA, Barren MJ, et al: Serum α-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst 1999;91:1738-1743.
37. Clark LC, Combs GF Jr, Turnbull BW, et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group [published erratum appears in JAMA 1997;277:1520]. JAMA 1996;276:1957-1963.
38. Blot WJ, Li Jy, Taylor PR, et al: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-1492.
39. Lippman M, Brown PH: Tamoxifen prevention of breast cancer: an instance of the fingerpost. J Natl Cancer Inst 1999;91:1809-1819.
40. Sun SY, Yue P, Dawson MI, et al: Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res 1997;57:4931-49.39.
41. Wattenberg LW, Wiedmann TS, Estensen RD, et al: Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 1997;57:5489-5492.
42. Zou Y, Zong G, Ling YH, et al: Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes. J Natl Cancer Inst 1998;90:1130-1137.
43. Parthasarathy R, Gilbert B, Mehta K: Aerosol delivery of liposomal all-trans-retinoic acid to the lungs. Cancer Chemother Pharmacol 1999;43:277-283.
44. Massaro GD, Massaro D: Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats [published erratum appears in Nat Med 1997:3:805]. Nat Med 1997;3:675-677.
45. Pianezza ML, Sellers EM, Tyndale RF: Nicotine metabolism defect reduces smoking [letter]. Nature 1998;393(6687):750.
46. Spitz MR, Shi H, Yang F, et al: Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998;90:358-363.